Novira Therapeutics, Inc. clinical trials
Acquired by Johnson & Johnson, 2015 · source ↗
The registry lists 2 studies whose lead sponsor is Novira Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 18, 2017.
Before and after it joined Johnson & Johnson
- First submitted before Novira Therapeutics, Inc. became part of Johnson & Johnson
- 1
- First submitted after Novira Therapeutics, Inc. became part of Johnson & Johnson
- 0
- Unclear, or no submission date
- 1
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Novira Therapeutics, Inc.2 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Johnson & Johnson studies →
- Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B PatientsCompletedNCT02112799Phase 1
Sponsor listed in the registry: Novira Therapeutics, Inc. · First submitted before Novira Therapeutics, Inc. became part of Johnson & Johnson
- Dose-Ranging Study to Assess the Safety, PK and Initial Antiviral Efficacy of NVR 3-778 in Chronic HBV PatientsCompletedNCT02401737Phase 1
Sponsor listed in the registry: Novira Therapeutics, Inc. · Unclear whether first submitted before or after Novira Therapeutics, Inc. became part of Johnson & Johnson